# Cheniere Energy Inc. (LNG) — Financial Analysis

**Exchange:** NYSE  
**Coverage as of:** 2026-Q2  
**Updated:** 2026-05-28  
**Tier:** Free primer (step 2 of 19)  
**Sibling pages:** /stocks/LNG/thesis · /stocks/LNG/memo

## Financial Snapshot

---
step: 04
title: Financial Quality & Adversarial Sweep
source: coverage-next-full
ticker: LNG
company: Cheniere Energy, Inc.
created: 2026-05-28
---

### Step 04 — Financial Quality

#### Key Findings

- **Net positive for thesis (with caveats).** Underlying economic earnings (Adj EBITDA, DCF) are stable and rising; GAAP earnings are noisy due to large derivative MTM swings that are non-cash [S1].
- No revenue-recognition red flags. ASC 842 lease accounting and ASC 606 SPA recognition are standard and consistent with peer practice [S2].
- Adversarial sweep: no active short-seller reports of consequence; no SEC investigation; routine operating litigation only. No accounting scandals in company history [S3].
- Working capital negative in 1Q26 ($-3.1B) reflects MTM derivative liability spike; not operational distress.

#### Implications for Thesis and Valuation

- **Use Adj EBITDA + DCF as primary** valuation inputs; treat GAAP EPS as secondary/noisy.
- Normalize 1Q26 GAAP loss via adjusted EPS reconciliation in MD&A — actual cash economics intact.
- Free cash flow has compressed FY2024-2025 due to peak Stage 3 capex; ramps after 2026 as capex normalizes to ~$1-1.5B maintenance level.

#### Objective

Assess earnings quality (cash vs. accrual), identify any accounting red flags, complete the adversarial sweep (short reports, investigations, litigation), and confirm financial statements can be trusted as the basis for valuation.

#### Narrative Analysis

**Earnings quality:** Cheniere's reported GAAP net income is highly volatile (FY2021 -$2.3B, FY2022 $1.4B, FY2023 $9.9B, FY2024 $3.3B, FY2025 $5.3B, 1Q26 -$3.5B) [S1]. The volatility is not driven by operating cash economics but by **derivative mark-to-market accounting**: Cheniere has substantial hedge positions on Henry Hub feed gas and on certain SPA fair-value designations. When Henry Hub or international spot prices move sharply, the derivative book gets repriced through P&L, generating non-cash gains or losses that don't reflect underlying business performance [S1].

The "right" lens is **Consolidated Adjusted EBITDA** (the company's primary disclosed metric) and **Distributable Cash Flow (DCF)** [S2]. Both strip MTM volatility and exclude SBC; they reflect the cash spreadable to debt service, dividends, and buybacks. Adj EBITDA trajectory:
- FY2022 $11.7B (spike, post-Ukraine spot windfall)
- FY2023 $8.8B (normalization but still elevated spread)
- FY2024 $6.2B (further normalization)
- FY2025 ~$7.0B (Stage 3 Train 1 contribution + better realized pricing)
- FY2026 guidance $7.25-7.75B (raised twice during the year)

DCF trajectory similar: $8.6B → $6.5B → $3.7B → $4.6B → $4.75-5.25B guide.

The takeaway: **operating cash economics have been stable-to-rising even as GAAP EPS swings**. The 1Q26 GAAP loss of $3.5B was paired with **adjusted EPS of $4.77** — a beat versus consensus $3.91 [S2].

**Revenue recognition:** SPA take-or-pay revenue is recognized over the period the buyer has the right to lift (ASC 606); marketing/spot recognized at delivery. Pipeline tolling recognized over service period. No aggressive front-loading or bill-and-hold issues evident in 10-K footnote disclosures [S2].

**Balance sheet integrity:** Total debt ~$25.5B is mostly **project-level non-recourse** at SPL (CQP sub) and CCH levels, with parent-level debt minimal — investment-grade rated [S2]. The negative book equity in FY2022 (-$171M) was an AOCL artifact from MTM hedge liabilities; resolved as hedges rolled off, equity now $13B [S1].

**Capex and FCF quality:** Capex has risen with the Stage 3 + Midscale 8-9 build cycle (FY21 $966M → FY25 $3,078M). Free cash flow compressed in FY24-25 because of peak growth capex but remains positive [S1]. Normalized maintenance capex is closer to $0.8-1.0B/year; expansion capex will continue through 2028 (Midscale 8-9 buildout).

**SBC dilution:** ~$130-160M/year in SBC, small relative to FCF and offset many times over by ~$2.5-2.8B/year buybacks.

##### Adversarial Research Sweep

**Short reports:** Tavily search surfaced no recent material short-seller reports targeting Cheniere. Short interest is low: 4.31M shares (~2% of float) per StockAnalysis.com [S4]. No Hindenburg / Muddy Waters / Kerrisdale exposes found.

**SEC/DOJ investigations:** No active investigations of note. The company has routine SEC comment letters typical of large issuers; nothing involving accounting restatements [S3].

**Litigation:** Routine: gas supply contract disputes, environmental permitting opposition, employment matters. No outsized contingent liability disclosed in 10-K MD&A [S3]. Notable: Venture Global (competitor) has been sued by major counterparties (Shell, BP, Repsol) over LNG delivery delays — this is a **competitive risk benefit** to Cheniere (highlights its execution advantage), not a Cheniere risk.

**Accounting concerns:** No restatements in last 5 years. KPMG audit opinion clean. ICFR effective per 10-K Item 9A.

**Insider activity (Q4 2025 / Q1 2026):** CFO Davis sold 29K @ ~$300 (likely 10b5-1); routine director RSU grants. No insider buying, no clustering of sales that would suggest insider concern [S5]. Net signal: neutral.

**Hedge book complexity:** This is the one area requiring attention. Cheniere uses commodity derivatives (gas, LNG, FX, interest rate). The notional book is large and disclosure is technical. Investors should:
1. Track derivative MTM impact in EPS reconciliation
2. Watch the AOCL line on balance sheet
3. Rely on Adj EBITDA, not GAAP NI, for run-rate

This is a **valid concern** for valuation methodology but does NOT indicate financial misconduct — it's the price of operating a commodity-tolling business that hedges contractual exposures.

#### Evidence and Sources

LNG_financials/xbrl/xbrl_summary.md, 10-K summaries, stockanalysis_summary.md.

#### Assumption Register Updates

- A05 (reinforced): Adj EBITDA reflects underlying economics; GAAP NI distorted by derivative MTM (Judgment, High)

#### Tables and Calculations

##### Earnings Quality — GAAP vs Adj (USD M)

| Year | GAAP NI | Adj EBITDA | DCF | Comment |
|------|---------|------------|-----|---------|
| 2021 | (2,343) | ~5,500 | n/a | Hedge MTM loss |
| 2022 | 1,428 | ~11,650 | ~8,650 | Hedge MTM offset gains; pure cash strong |
| 2023 | 9,881 | ~8,800 | ~6,500 | Hedge gains accelerated GAAP |
| 2024 | 3,252 | 6,162 | 3,720 | Normalized |
| 2025 | 5,330 | ~7,030 | ~4,640 | Stage 3 Train 1 |
| 1Q26 | (3,502) | ~$1.9B (est) | ~$1.4B (est) | GAAP loss, adj EPS +22% beat |

##### Free Cash Flow & Capital Discipline (USD M)

| Year | OCF | Capex | FCF | Buybacks | Dividends | Net Debt Δ |
|------|-----|-------|-----|----------|-----------|------------|
| 2021 | 2,469 | (966) | 1,503 | (57) | (85) | -899 (paydown) |
| 2022 | 10,523 | (1,830) | 8,693 | (1,436) | (349) | -5,196 (paydown) |
| 2023 | 8,418 | (2,121) | 6,297 | (1,536) | (393) | -1,201 (paydown) |
| 2024 | 5,394 | (2,238) | 3,156 | (2,308) | (412) | -796 (paydown) |
| 2025 | 5,539 | (3,078) | 2,461 | (2,775) | (451) | -105 (paydown) |

Pattern: aggressive debt paydown 2022-2024 then pivot to capital return at constant balance sheet.

##### Adversarial Sweep Scorecard

| Vector | Status | Severity |
|--------|--------|----------|
| Short-seller report | None active | N/A |
| SEC/DOJ investigation | None | N/A |
| Class-action litigation | None material | N/A |
| Accounting restatement | None (5y) | N/A |
| Auditor opinion | Clean (KPMG) | N/A |
| Insider clustering | None | Low |
| Hedge MTM complexity | Real but legitimate | Med (use Adj metrics) |
| Counterparty disputes | Counterparties suing VG, not LNG | Positive read |

#### Open Questions and Data Gaps

- Detailed derivative book composition (Henry Hub forward curve assumption sensitivity) — only summary disclosure in 10-K.
- Exact tax sheltering from CQP MLP structure flow-through — handled in tax note but complex.

#### Next-Step Dependencies

Step 05 will reuse Adj EBITDA + DCF run-rate trajectory for quarterly momentum lens.

#### Source Index

| Tag | Document / URL | Section | Date | Notes |
|-----|---------------|---------|------|-------|
| [S1] | xbrl_summary.md | Income statement + balance sheet history | 2026-05-28 | StockAnalysis aggregation |
| [S2] | LNG 10-K FY2024 + FY2025 | Revenue recognition, Adj EBITDA reconciliation | 2025-2026 | 10K summaries |
| [S3] | LNG 10-K FY2024 Item 1A + 3 | Risk factors + legal proceedings | 2025-02 | 10K_FY2024_summary.md |
| [S4] | StockAnalysis.com statistics | Short interest | 2026-05-28 | stockanalysis_summary.md |
| [S5] | secform4 / stocktitan Form 4 sweep | Q4 2025 - Q1 2026 | 2026-05-28 | insider_transactions.md |
| [S6] | Reuters/Bloomberg coverage of VG litigation | Shell, BP, Repsol vs VG | 2024-2025 | media coverage |

## Deeper Financial Analysis

The fundamental tier ($1.00) adds 8 dimensions not included here:

- Revenue Breakdown — segment revenue, geographic mix, product-line margins
- Financial Trends — QoQ momentum, leading indicators, inflection points
- Balance Sheet — debt structure, dilution risk, working capital dynamics
- Capital Allocation — ROIC, buyback cadence, reinvestment efficiency
- Earnings Analysis — beats/misses, guidance vs actuals, transcript highlights
- Competitive Positioning — market share, pricing power, peer benchmarks
- Industry Context — TAM, sector tailwinds/headwinds, regulatory backdrop

**API endpoint:** GET /api/v1/research/LNG/fundamental

## Navigation

- Overview: /stocks/LNG
- Financials (this page): /stocks/LNG/financials
- Thesis: /stocks/LNG/thesis
- Investment Memo: /stocks/LNG/memo
- Coverage universe: /stocks